#Synthetic Genomics Inc

[tamanna31]

New Trends of Oligonucleotide Synthesis Market with Industry Analysis by 2024 – 2030

Oligonucleotide Synthesis Industry Overview

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

·         Thermo Fisher Scientific, Inc.

·         Merck KGaA

·         Danaher Corporation

·         Dharmacon Inc.

·         Agilent Technologies

·         Bio-synthesis

·         Kaneka Eurogentec S.A

·         LGC Biosearch Technologies

·         Biolegio

·         Twist Bioscience

Recent Developments

In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.

[tushar38]

Molecular Cloning Kits Market: Growth Factors and Challenges

Introduction to Molecular Cloning Kits Market

The Molecular Cloning Kits Market is experiencing robust growth, driven by the rising demand for genetic research and advancements in molecular biology. These kits, essential tools for gene cloning and recombinant DNA technology, are widely used in academic research, biotechnology, and pharmaceutical industries. With increasing investments in life sciences and the surge in personalized medicine, the market is poised for significant expansion. Additionally, technological innovations, such as automation and high-throughput capabilities, are enhancing the efficiency and accuracy of molecular cloning processes, further fueling market growth.Market overview

The Molecular Cloning Kits Market is Valued USD 431.84 Million in 2024 and projected to reach USD 1,250.25 Million by 2030, growing at a CAGR of CAGR of 16.4% During the Forecast period of 2024-2032.. The market is driven by advancements in synthetic biology, personalized medicine, and the demand for efficient cloning methods. Companies are focusing on developing user-friendly, high-precision kits to cater to the diverse needs of researchers and clinicians. Furthermore, the expansion of academic research, coupled with government funding, supports the market's upward trajectory.

Access Full Report :https://www.marketdigits.com/checkout/3824?lic=s

Major Classifications are as follows:

By Application

Gene Expression

Gene Editing

Functional Analysis

Genome Engineering

Diagnostics and Therapeutics

By End-user

Academic & Research Institutions

Pharmaceutical & Biotechnology Companies

Hospitals & Clinics

Contract Research Organizations

Industrial Biotechnology Companies

Major players in Molecular Cloning Kits Market:

Thermo Fisher Scientific, Inc., Merck KGaA (Sigma-Aldrich), New England Biolabs, Inc, Agilent Technologies, Inc, Qiagen N.V., Takara Bio Inc., Promega Corporation, Illumina, Inc, Clontech Laboratories (a Takara Bio Company), Bio-Rad Laboratories, Inc., and Others

Market Drivers in Molecular Cloning Kits Market

Advancements in Genetic Research: Ongoing innovations in genetic engineering, such as CRISPR-Cas9, gene editing, and synthetic biology, have increased the demand for reliable and efficient molecular cloning kits. These advancements enable more precise and rapid DNA manipulation, making cloning kits essential tools for modern molecular biology labs.

Rising Demand for Personalized Medicine: Personalized medicine relies heavily on genetic analysis and modifications, driving the need for molecular cloning technologies. The ability to clone specific genes or sequences is crucial for developing targeted therapies and diagnostics tailored to individual genetic profiles.

Growth in Biopharmaceutical and Biotechnology Sectors: The expanding biopharmaceutical industry is a major driver, as molecular cloning is integral to the production of recombinant proteins, monoclonal antibodies, and other biologic drugs. Increased R&D investments in these sectors are boosting the demand for cloning kits.

Market Challenges in Molecular Cloning Kits Market

High Costs of Advanced Cloning Technologies: The cost of molecular cloning kits, especially those featuring advanced technologies such as high-fidelity enzymes and complex vectors, can be prohibitively expensive for smaller labs and academic institutions with limited budgets. These costs can limit the adoption of state-of-the-art cloning solutions, particularly in developing regions.

Complexity of Cloning Procedures: Molecular cloning can be a technically demanding process that requires expertise in genetic manipulation and a deep understanding of the underlying biological systems. The complexity of the procedures can pose a barrier to entry for new users and may lead to variability in results, affecting the reproducibility and reliability of experiments.

Regulatory and Ethical Concerns: The regulatory landscape for genetic research, including cloning, is complex and varies significantly across regions. Ethical concerns regarding genetic manipulation, particularly in the context of human and animal genetics, can lead to stringent regulations and restrictions that impact market growth. Navigating these regulatory environments can be challenging for companies operating in this space.

Market Opportunities of Molecular Cloning Kits Market

Expansion in Emerging Markets: Rapid advancements in research infrastructure in emerging economies, such as China, India, and Brazil, present significant opportunities for market expansion. Increased investments in biotechnology and life sciences in these regions, supported by government initiatives, create a conducive environment for the adoption of molecular cloning technologies.

Rising Demand in Synthetic Biology and Gene Therapy: The growing fields of synthetic biology and gene therapy provide substantial growth opportunities for molecular cloning kits. As researchers develop novel therapies and synthetic organisms, the demand for precise and efficient cloning solutions will rise, fueling the market's growth.

Development of Automated and High-Throughput Cloning Systems: The trend towards automation and high-throughput technologies in molecular biology offers a significant opportunity for cloning kit manufacturers. Automated systems reduce labor intensity, minimize errors, and increase the efficiency of cloning processes, making them attractive to both research institutions and commercial labs.

Conclusion:

The Molecular Cloning Kits Market is positioned for continued growth, underpinned by technological innovations and expanding research applications in various fields, including healthcare, agriculture, and environmental sciences. While the market faces challenges like high costs and regulatory hurdles, the rising demand for efficient and accurate cloning methods provides ample opportunities for growth. As the landscape of molecular biology evolves, the development of advanced, user-friendly cloning kits will be critical in addressing the needs of researchers and clinicians worldwid

[trendtrackershq]

𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.nextmsc.com/synthetic-biology-market/request-sample

In a world where innovation is the key to solving complex global challenges, the 𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 is emerging as a game-changer. With the power to design and engineer biological systems for new functions, this field is revolutionizing industries ranging from healthcare to agriculture and energy.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡: The Synthetic Biology Market is poised for exponential growth, driven by advancements in gene editing, bioengineering, and AI. The potential applications are vast, from sustainable biofuels to groundbreaking medical therapies.

𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬: As we look to the future, synthetic biology offers solutions to some of the most pressing issues of our time—climate change, food security, and personalized medicine. By harnessing nature's building blocks, we're creating a more sustainable and innovative world.

𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐭𝐨 𝐖𝐚𝐭𝐜𝐡:

𝐂𝐑𝐈𝐒𝐏𝐑 𝐚𝐧𝐝 𝐆𝐞𝐧𝐞 𝐄𝐝𝐢𝐭𝐢𝐧𝐠: Precision in modifying genetic material is opening new doors.

𝐁𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠: A sustainable approach to producing chemicals, materials, and fuels.

𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Personalized treatments and vaccines that adapt to individual needs.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Thermo Fisher Scientific Inc. 

Merck KGaA

Agilent Technologies Inc. 

Novozymes A/S

Ginkgo Bioworks, 

Amyris, Inc. 

Precigen, Inc.

GenScript Biotech Corporation 

Twist Bioscience

Synthetic Genomics Inc.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.nextmsc.com/report/synthetic-biology-market

𝐓𝐡𝐞 𝐈𝐦𝐩𝐚𝐜𝐭: This is not just a trend; it's a transformative shift that will redefine industries and improve lives globally. The Synthetic Biology Market is where science meets innovation, and the possibilities are endless.

[creativecontentcraze]

Rising Demand For Pharmaceutical Excipients To Boost Microcrystalline Cellulose Market Growth

The global microcrystalline cellulose market is estimated to be valued at US$ 1349.84 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Microcrystalline cellulose is a partially depolymerized cellulose prepared by treating alpha cellulose, obtained as a pulp from fibrous plant materials, with mineral acids. It is commonly used as a diluent, binder, suspension agent and thickening agent in pharmaceutical formulations as well as in food & beverage industries. Microcrystalline cellulose provides advantages such as better flow properties, low density, excellent binding properties, good compaction characteristics and high compatibility with other excipients. The use of microcrystalline cellulose in pharmaceutical excipients is growing owing to increasing demand for tablets and capsules globally which will drive the market during forecast period. Key Takeaways - Key players operating in the microcrystalline cellulose market are Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Genomics, QIAGEN, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio, Zymo Research Corporation, Oxford Nanopore Technologies plc, Tecan Trading AG, Hamilton Company, ZS Genetics, Inc. LI-COR, Inc. - Growing demand for pharmaceutical excipients from the pharmaceutical industry is one of the major factors driving the growth of the microcrystalline cellulose market. Tablets and capsules are the most commonly used dosage forms across the globe which requires excipients like microcrystalline cellulose in large quantities. - Technological advancements in microcrystalline cellulose production methods helps in improving product attributes such as flowability, compressibility, diluent properties etc. Continuous innovations in particle engineering techniques helps manufacturers develop application-specific microcrystalline cellulose grades. Market Trends - Growing preference for plant-based excipients: Regulatory authorities are promoting use of plant-based excipients over synthetic ones. This drives demand for naturally-sourced microcrystalline cellulose. - Development of multifunctional microcrystalline cellulose market grades: Manufacturers are developing microcrystalline cellulose with additional properties like disintegration, binder etc. to simplify formulation design. Market Opportunities - Emerging markets in Asia Pacific and Middle East & Africa: Growth in pharmaceutical manufacturing in these regions owing to low production cost and increasing demand offer opportunities for microcrystalline cellulose suppliers. - Alternative applications: Microcrystalline cellulose finds increasing usage in non-pharmaceutical applications like food, paints, coatings industries due to its functional properties. Impact of COVID-19 on Microcrystalline Cellulose Market The outbreak of the COVID-19 pandemic has significantly impacted the growth of the microcrystalline cellulose market. The imposition of nationwide lockdowns led to the temporary closure of manufacturing facilities across major regions like North America, Europe, and Asia Pacific. This disrupted supply chains and reduced the procurement of raw materials required for the production of microcrystalline cellulose. With restrictions on travel and transportation, the logistics and delivery of finished products were also interrupted. The pandemic also caused a decline in consumer spending on non-essential items like processed foods and pharmaceuticals where microcrystalline cellulose finds widespread applications. This restrained the demand from end-use industries in the initial months of the pandemic.

In terms of value, the North American region accounted for the major share of the global microcrystalline cellulose market in 2024. This can be attributed to growing healthcare expenditure and high consumption of processed and packaged foods where microcrystalline cellulose finds widespread application as an additive, binder, disintegrant, and stabilizer. The growing prevalence of lifestyle diseases coupled with an aging population has stimulated the regional demand for pharmaceuticals over the years and boosted microcrystalline cellulose procurement. Further, the presence of leading pharmaceutical companies in countries like the US and Canada also drives market growth through increased outsourcing of microcrystalline cellulose production.

Get More Insights On, Microcrystalline Cellulose Market

About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[researchanalysts]

Whole Genome Synthesis Market: Unlocking the Potential of Synthetic Biology for Research and Industrial Applications

The Whole Genome Synthesis Market is Valued at USD 2.4 billion in 2019 and projected to reach USD 13.03 billion by 2027, growing at a CAGR of 26% During the Forecast period of 2024–2032.

Introduction: Whole Genome Synthesis represents a revolutionary advancement in synthetic biology, enabling the construction of entire genomes from scratch. This technology allows for the creation of customized organisms with tailored genetic traits, opening new frontiers in research, medicine, agriculture, and biotechnology. By synthesizing DNA sequences de novo, scientists can design organisms to produce biofuels, pharmaceuticals, and other valuable compounds, thereby accelerating innovation across multiple industries.

Download a Free Sample Copy of the Report: https://www.marketdigits.com/request/sample/274

Key Manufacturers: ➢ J. Craig Venter Institute,  ➢ Ansa Biotechnologies,  ➢ Twist Bioscience,  ➢ Integrated DNA Technologies,  ➢ Thermo Genewiz Eurofins Scientific,  ➢ Quintara Biosciences, ATD Bio Ltd.,  ➢ Fisher Scientific, Inc.,  ➢ OriGene Technologies, Inc,  ➢ Bioneer Corporation,  ➢ Atum,  ➢ Icon Genetics

Why Should Access to This Report? Access to this comprehensive report on the Whole Genome Synthesis Market is crucial for stakeholders, researchers, and industry leaders aiming to stay ahead in this rapidly evolving field. The report provides in-depth insights into market trends, technological advancements, and key players driving the market. It also highlights potential challenges and opportunities, offering a strategic roadmap for investment and development. By understanding the current landscape and future projections, stakeholders can make informed decisions and leverage emerging opportunities in synthetic biology.

Inquire Before Buying at — https://www.marketdigits.com/request/enquiry-before-buying/274

Major Classifications are as follows:

By Application ➲ Chemical & Specialty Chemical ➲ Biotechnology ➲ Pharmaceutical ➲ Farming Sector

By Region ➲ North America ➲ Europe ➲ Middle East and Africa (MEA) ➲ Asia-Pacific (APAC)

The objective of this study is to identify the market opportunities and estimate market size by segments and countries for the last few years and to forecast the values for the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis of the market, by incorporating complete pricing and cost analysis of components & products, Porter’s analysis, and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field.

Click to Request Free 10% Customization on this Report @ https://www.marketdigits.com/request/customization/274

Reason to Purchase this Report:

✤ Determine prospective investment areas based on a detailed trend analysis of the global market over the next years. ✤ Gain an in-depth understanding of the underlying factors driving demand for different market segments in the top spending countries across the world and identify the opportunities offered by each of them. ✤ Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others. ✤ Identify the major channels that are driving the global market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion. ✤ Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global market. ✤ Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top market providers around the world which include information about their products, alliances, recent contract wins, and financial analysis wherever available.

Conclusion: The Whole Genome Synthesis Market is poised for significant growth, driven by advancements in synthetic biology and increasing demand for genetically engineered organisms. 

This report provides a comprehensive analysis of the market, offering valuable insights for stakeholders to navigate the complexities and seize opportunities in this dynamic field. By leveraging the information presented, businesses and researchers can drive innovation, enhance productivity, and contribute to the development of cutting-edge biotechnological solutions.

Request for Discount @ https://www.marketdigits.com/request/discount/274

[bhushans]

The Rise of Tech-Driven Therapies: Reshaping the Global Synthetic Biology Market

The global Synthetic Biology market is set for exponential growth, with an expected increase from USD 3.75 billion in 2024 to a staggering USD 31.73 billion by 2034. This impressive expansion corresponds to a compound annual growth rate (CAGR) of 23.8% over the forecast period.

The surge in the synthetic biology market is driven by the rising need to enhance practical capabilities, redesign naturally occurring systems, and develop new biological components, tools, and systems. These advancements are paving the way for innovative applications across various industries, including healthcare, agriculture, and environmental management.

Request Your Detailed Report Sample With Your Work Email: https://www.futuremarketinsights.com/reports/sample/rep-gb-1226

Its rapid expansion is being driven by the revolution that synthetic biology is bringing to numerous businesses and tackling pressing global concerns. The market is driven by its ability to revolutionize industries and provide cutting-edge answers to urgent problems.

Key Takeaways:

The synthetic biology market is projected to surge from US$3.75 billion in 2024 to US$31.73 billion by 2034, reflecting a remarkable CAGR of 23.8%.

Rising demand for enhanced functionalities, redesigned natural systems, and novel biological tools are fueling market growth.

Synthetic biology holds immense potential in addressing critical challenges related to bio-based chemicals, renewable fuels, and affordable medications.

The need for genetically modified crops to ensure global food security is further propelling advancements in the field.

The convergence of technological breakthroughs and growing market needs positions synthetic biology as a key solution provider for social and environmental concerns, fostering further innovation in the coming years.

Demand for sustainable solutions: Businesses and consumers alike are looking for more environmentally friendly options. The field of synthetic biology has promise for the development of bio-based compounds, renewable fuels, and more reasonably priced pharmaceuticals and vaccinations. Synthetic biology solutions are becoming increasingly in demand as a result of this move towards sustainable practices. Concerns about food security: To maintain food security in the face of an increasing global population, creative solutions are required. Developments in synthetic biology are essential to the creation of genetically engineered crops with increased resistance and yields. The potential for this technology to alleviate the world’s food shortages is enormous.

Recent Developments in the Synthetic Biology Industry

In January 2024, Rice University established the Rice Synthetic Biology Institute (RSBI) in Texas to promote collaborative research in synthetic biology and convert it into beneficial technologies. The institute aims to attract global attention to Rice’s esteemed synthetic biology program and retain top talent.

In January 2024, Kerstin Göpfrich founded a research group at the Max Planck Institute for Medical Research in Heidelberg, Germany. The group focuses on engineering life and exploring new cell abilities to create new life forms.

In November 2023, the United Kingdom-based team led by Ben Blount at the University of Nottingham developed a yeast strain with over 50% synthetic DNA, a significant achievement in the Saccharomyces cerevisiae (Sc) 2.0 project, a global effort to produce synthetic versions of the yeast genome.

In July 2023, WPI researchers Eric Young and Kevin Keating developed a method to express genes across bacterial species by designing a generalized collection of DNA parts that can be used with multiple species to assemble DNA sequences.

Key Companies in the Synthetic Biology Market:

Thermo Fisher Scientific, Inc.

Merck KGaA

Novozymes

Agilent Technologies, Inc.

Codexis, Inc.

Bota Biosciences Inc.

Creative Biogene.

Creative Enzymes.

Enbiotix, Inc.

Illumina, Inc.

Eurofins Scientific

New England Biolabs

Pareto Bio, Inc.

Scarab Genomics, Llc

Synthego

Twist Bioscience

Synthetic Genomics Inc.

BioBricks Foundation

DIYbio

Amyris

Cyrus Biotechnology

TeselaGen

Key Segments:

By Product:

Oligonucleotides

Enzymes

Synthetic Cells

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

By Application:

Healthcare

Non-Healthcare

By End User:

Biopharmaceutical manufacturers

Academic and Government Research Institutes

Others

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

[simranmakhija1]

Regulatory Considerations in the DNA and Gene Cloning Services Market

The DNA and Gene Cloning Services Market is experiencing significant growth driven by the increasing demand for custom DNA constructs, genetically engineered organisms, and gene editing services in various fields, including biotechnology, pharmaceuticals, agriculture, and research. Gene cloning, the process of replicating and amplifying specific DNA sequences, plays a crucial role in molecular biology research, drug discovery, and biomanufacturing.

Get a free Sample: https://www.marketdigits.com/request/sample/3785 

One of the primary drivers of market growth is the expanding applications of gene cloning and genetic engineering in biopharmaceutical production. Recombinant DNA technology allows for the production of therapeutic proteins, antibodies, vaccines, and gene therapies, offering potential treatments for a wide range of diseases, including cancer, genetic disorders, and infectious diseases. As a result, pharmaceutical companies and biotech firms are increasingly outsourcing gene cloning services to specialized providers to expedite their drug development pipelines and reduce time-to-market.

Furthermore, advancements in gene editing technologies, such as CRISPR-Cas9, TALENs, and zinc finger nucleases, have revolutionized the field of genetic engineering, enabling precise modifications of DNA sequences in various organisms. Gene editing services, including gene knockout, knock-in, and point mutation, are in high demand for applications such as functional genomics, cell line engineering, and agricultural biotechnology. Additionally, the emergence of synthetic biology and genome editing platforms has created new opportunities for engineering custom DNA constructs and genetic circuits for biomanufacturing and biotechnology applications.

The DNA and Gene Cloning Services Market is Valued USD 3.02 billion in 2024 and projected to reach USD 7.84 billion by 2030, growing at a CAGR of CAGR of 14.6% During the Forecast period of 2024-2032.

The DNA and gene cloning services market is characterized by the presence of specialized providers offering a wide range of services, including gene synthesis, gene cloning, gene editing, plasmid preparation, and DNA sequencing. Major players in the market include Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Eurofins Scientific SE, Integrated DNA Technologies, Inc. (IDT), and OriGene Technologies, Inc., among others. These companies provide end-to-end solutions for DNA manipulation, from design and synthesis to cloning and validation, catering to the diverse needs of academic research labs, biotech startups, and pharmaceutical companies worldwide.

Major vendors in the global DNA and Gene Cloning Services Market are Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience and Others

Emerging trends in the DNA and gene cloning services market include the development of high-throughput cloning platforms, automation technologies, and cloud-based bioinformatics tools for DNA design and analysis. These advancements enable researchers to streamline the gene cloning process, reduce experimental variability, and accelerate scientific discovery. Additionally, there is growing interest in gene synthesis and DNA assembly methods that enable the construction of large, complex DNA sequences, such as gene clusters, pathways, and synthetic genomes, for applications in synthetic biology and metabolic engineering.

Looking ahead, the DNA and gene cloning services market is poised for continued growth driven by advancements in genomics, gene editing, and biomanufacturing technologies. As the demand for custom DNA constructs and genetically engineered organisms continues to rise, specialized service providers will play a critical role in supporting research, drug development, and biotechnology innovation. Collaborations between industry stakeholders, academic institutions, and regulatory agencies will be essential in addressing technical challenges, ensuring quality standards, and facilitating the translation of genetic engineering advancements into real-world applications.

[electronalytics]

Synthetic Biology Market Analysis, Outlook & Forecast till 2033

Synthetic Biology Market was valued at USD 15.47 billion in 2023 to USD 78.51 billion in 2033,  and is expected to expand at a compound annual growth rate (CAGR) of 18.97% from 2024 to 2033.

Introduction:

The Synthetic Biology Market is a rapidly growing field focused on the design and engineering of biological systems. It utilizes principles from engineering, computer science, and molecular biology to create new or modify existing biological components and functions. This market caters to a wide range of applications across various industries.

Definition:

Synthetic biology involves the manipulation of genetic components like DNA and RNA to create novel biological systems or reprogram existing ones for specific purposes. It allows scientists to design and build cells with specific functionalities, unlike traditional genetic modification which primarily focuses on altering single genes.

Market Trends:

Several key trends are driving the Synthetic Biology Market:

Personalized Medicine: Synthetic biology holds immense potential for developing personalized medicine therapies by engineering cells to target specific diseases or create customized treatments.

Biomanufacturing: This market is witnessing a surge in the use of synthetic biology to engineer organisms for the efficient production of valuable bioproducts like pharmaceuticals, biofuels, and biomaterials.

Agriculture: Synthetic biology offers solutions for improving crop yields, enhancing pest resistance, and developing stress-tolerant crops.

Environmental Applications: This field holds promise for bioremediation, creating microbes to clean up pollutants, and developing biofuels as a sustainable energy source.

Objectives of the Market:

Developing Novel Products & Processes: The primary objective is to leverage the power of synthetic biology to create new products and processes in various industries.

Optimizing Existing Biological Systems: This market aims to improve the efficiency and functionality of existing biological systems through targeted engineering.

Addressing Global Challenges: Synthetic biology holds the potential to address global challenges like food security, energy production, and environmental sustainability.

Market Scope:

The Synthetic Biology Market can be segmented based on various factors:

Technology: DNA synthesis, gene editing, metabolic engineering

Application: Personalized medicine, biomanufacturing, agriculture, environmental applications

Product Type: Enzymes, microorganisms, biomaterials

End-Use Industry: Pharmaceuticals, chemicals, agriculture, energy, environmental services

Geographic Region: North America, Europe, Asia Pacific, etc.

Understanding these segments helps market players identify potential opportunities and develop targeted solutions.

Conclusion:

The Synthetic Biology Market is at the forefront of scientific advancement with the potential to revolutionize various industries. As research and development progress, and ethical considerations are addressed, this market is expected to witness significant growth and contribute to solving global challenges in healthcare, agriculture, and environmental sustainability.

Receive the FREE Sample Report of Synthetic Biology Market Research Insights @ https://stringentdatalytics.com/sample-request/synthetic-biology-market/13380/

Market Segmentations:

Global Synthetic Biology Market: By Company • Bota Biosciences Inc. • Codexis, Inc. • Creative Biogene. • Creative Enzymes. • Enbiotix, Inc. • Illumina, Inc. • Merck Kgaa (Sigma-Aldrich Co. Llc) • New England Biolabs • Euro fins Scientific • Novozymes • Pareto Bio, Inc. • Scarab Genomics, Llc • Synthego • Synthetic Genomics Inc. • Thermo Fisher Scientific, Inc. Global Synthetic Biology Market: By Type • Synthetic DNA • Synthetic Oligos • Synthetic Genes • Software Tools • Chassis Organisms • Synthetic Clones • Synthetic Cells Global Synthetic Biology Market: By Application • Pharmaceuticals & Diagnostics • Chemicals • Biofuels • Bioplastics • Others (Environment, Agriculture & Aquaculture)

Regional Analysis of Global Synthetic Biology Market

All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Synthetic Biology market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Click to Purchase Synthetic Biology Market Research Report @ https://stringentdatalytics.com/purchase/synthetic-biology-market/13380/?license=single

Key Report Highlights:

Key Market Participants: The report delves into the major stakeholders in the market, encompassing market players, suppliers of raw materials and equipment, end-users, traders, distributors, and more.

Comprehensive Company Profiles: Detailed company profiles are provided, offering insights into various aspects including production capacity, pricing, revenue, costs, gross margin, sales volume, sales revenue, consumption patterns, growth rates, import-export dynamics, supply chains, future strategic plans, and technological advancements. This comprehensive analysis draws from a dataset spanning 12 years and includes forecasts.

Market Growth Drivers: The report extensively examines the factors contributing to market growth, with a specific focus on elucidating the diverse categories of end-users within the market.

Data Segmentation: The data and information are presented in a structured manner, allowing for easy access by market player, geographical region, product type, application, and more. Furthermore, the report can be tailored to accommodate specific research requirements.

SWOT Analysis: A SWOT analysis of the market is included, offering an insightful evaluation of its Strengths, Weaknesses, Opportunities, and Threats.

Expert Insights: Concluding the report, it features insights and opinions from industry experts, providing valuable perspectives on the market landscape.

Report includes Competitor's Landscape:

➊ Major trends and growth projections by region and country ➋ Key winning strategies followed by the competitors ➌ Who are the key competitors in this industry? ➍ What shall be the potential of this industry over the forecast tenure? ➎ What are the factors propelling the demand for the Synthetic Biology? ➏ What are the opportunities that shall aid in significant proliferation of the market growth? ➐ What are the regional and country wise regulations that shall either hamper or boost the demand for Synthetic Biology? ➑ How has the covid-19 impacted the growth of the market? ➒ Has the supply chain disruption caused changes in the entire value chain? Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@stringentdatalytics.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1 346 666 6655 to share your research requirements.

About Stringent Datalytics

Stringent Datalytics offers both custom and syndicated market research reports. Custom market research reports are tailored to a specific client's needs and requirements. These reports provide unique insights into a particular industry or market segment and can help businesses make informed decisions about their strategies and operations.

Syndicated market research reports, on the other hand, are pre-existing reports that are available for purchase by multiple clients. These reports are often produced on a regular basis, such as annually or quarterly, and cover a broad range of industries and market segments. Syndicated reports provide clients with insights into industry trends, market sizes, and competitive landscapes. By offering both custom and syndicated reports, Stringent Datalytics can provide clients with a range of market research solutions that can be customized to their specific needs.

Reach US

Stringent Datalytics

sales@stringentdatalytics.com

+1 346 666 6655

Social Channels:

Linkedin | Facebook | Twitter | YouTube

[machineryequipment]

Global Synthetic Biology Market Size, Trends & Growth Opportunity, By Product (Synthetic DNA, Synthetic Genes, Synthetic Oligos, Software Tools, Chassis Organisms, Synthetic Clones, and synthetic Cells),By Technology (Bioinformatics, Microfluidics, and Genetic engineering), By Application, By Region and Forecast till 2030

Overview

The global synthetic biology market size was valued at USD 13.09 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 18.97% 2030.

Synthetic biology is defined as novel area of research which is the amalgamation of multiple disciplines like molecular biology, biotechnology, genetic engineering, biophysics, and others. It involves design and construction of new biological systems from standardized genetic components coupled with essential redesign of existing life for new purposes.

Market segmentation

Global Synthetic Biology Market is segmented into product such as Synthetic DNA, Synthetic Genes, Synthetic Oligos, Software Tools, Chassis Organisms, Synthetic Clones, and synthetic Cells, by technology such as Bioinformatics, Microfluidics, and Genetic engineering. Further, market is segmented into application such as Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplatics, and Others.

Also, Global Synthetic Biology Market is segmented on the basis of five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market key players

Various key players are discussed in this report such as Thermo Fisher Scientific, Inc., Codexis, Inc., Synthetic Genomics, Inc, Twist Bioscience, Genscript Biotech Corporation, Intrexon Corporation, Amyris, Inc., Ginkgo Bioworks, Novozymes A/S, Agilent Technologies, Inc,, and Merck Kgaa

About Us:

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.

QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.

QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.

Contact Us

     6060 N Central Expy #500 TX 75204, U.S.A

     sales@qualiketresearch.com

     +1 214 660 5449

     1201, City Avenue, Shankar Kalat Nagar,

     Wakad, Pune 411057, Maharashtra, India

     sales@qualiketresearch.com

     +91 9284752585

     Sharjah Media City , Al Messaned, Sharjah, UAE.

     sales@qualiketresearch.com

     +971 56 846 4312

[meghanester]

Human Microbiome Market Future Trends, Growth with a CAGR of ~25% and Attain ~USD 3400 Million 2023-2035

Research Nester’s recent market research analysis on “Human Microbiome Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the global human microbiome market in terms of market segmentation by product, disease type, organism type, application, technology, and by region.

Growing Prevalence of Gastrointestinal Disorders to Promote Global Market Share of Human Microbiome

The global human microbiome market is estimated to grow majorly on account of the growing elderly population across the globe. Older people are more susceptible to illnesses such as diabetes, and it is predicted that the growing elderly population around the world will fuel market expansion. Alterations in the gut microbiota have been associated with aging-related inflammation, which is thought to contribute to diseases including Alzheimer's, cardiovascular disease, and osteoporosis. The proportion of people 65 and older in the world's population increased by more than 8% in 2019.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4062

Some of the major growth factors and challenges that are associated with the growth of the global human microbiome market are:

Growth Drivers:

Surge in Health Spending

Rising Cases of Respiratory Diseases

Challenges:

The stringent regulations by the government and the absence of knowledge about human microbiome products are some of the major factors anticipated to hamper the global market size of human microbiomes.

Request for customization @ https://www.researchnester.com/customized-reports-4062

By product, the global human microbiome market is segmented into probiotics, prebiotics, diagnostic tests, drugs, and others. The probiotics segment is to garner the highest revenue by the end of 2035 by growing at a significant CAGR over the forecast period. The rising incidence of digestive diseases can be linked to the segment's expansion.

By region, the North American human microbiome market is to generate the highest revenue by the end of 2035. This growth is anticipated by a higher number of lifestyle diseases. Also, it is projected that an increase in government initiatives to fund human health research and an increase in healthcare costs will fuel market expansion during the projection period.

This report also provides the existing competitive scenario of some of the key players of the global human microbiome market which includes company profiling of Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, Inc., Second Genome Inc., Synthetic Biologics, Inc., YSOPIA Bioscience, 4D pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc., and others.     

Obtain this Report @ https://www.researchnester.com/reports/human-microbiome-market/4062

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion, investment, etc. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[delvenservices]

Synthetic Biology Market Demand, Growth Rate, Trends & Forecast: 2028

Global Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application (Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The Global Synthetic Biology market size is projected to reach a CAGR of 9.8% from 2022 to 2028.

Synthetic Biology is a branch of biotechnology that encompasses various aspects like set of concepts, approaches, and tools within biotechnology which could be used for the modification or creation of biological organisms. It deals with the redesigning and engineering of the organisms in such a way that they are useful for a particular problem in medicine or agriculture.

Research and development in the sector long with the surged funding are some of the factors that have supported long-term expansion for Global Synthetic Biology Market.

COVID-19 had a positive effect on the market, as the clinical developments and research was very prominent in the sector.

Get the Free Research Sample Copy: https://www.delvens.com/get-free-sample/synthetic-biology-market-trends-forecast-till-2028

Regional Analysis

North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the presence of key players in the region and the increased expenditure on the research and developmental activities.

Key Players

Carl Zeiss AG

Creaform Inc.

Eley Metrology

FARO Technologies, Inc.

Hexagon AB

Keyence Corporation

Metronor

Mitutoyo Corporation

Nikon Metrology

Tokyo Seimitsu Co. Ltd

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/synthetic-biology-market-trends-forecast-till-2028

Recent Developmen ts

In January 2021, Frontia GlutenEx was brought into the market by Novozymes.

In February 2021, Merck joined hands with BioNTech for the supply lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for Global Synthetic Biology Market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Order for the Research Report at: https://www.delvens.com/checkout/synthetic-biology-market-trends-forecast-till-2028

Report Scope

Global Synthetic Biology Market is segmented into Tool, Technology, Application and region.

On the basis of Tool

Oligonucleotides and Synthetic DNA

Enzymes

Cloning Technologies Kits

Synthetic Cells

Chassis Organisms

Xeno-nucleic Acids                                  

On the basis of Technology

Gene Synthesis

Genome Engineering

Sequencing

Bioinformatics

Site-directed Mutagenesis

Cloning

Measurement and Modeling

Microfluidics

Nanotechnology

On the basis of Application

Medical Application

Pharmaceuticals

Drug Discovery and Therapeutics

Cancer Detection & Diagnostics

Other Drug Discovery and Therapeutic Applications

Artificial Tissue and Tissue Regeneration

Bio-synthesis

Stem Cell Regulation

Other Tissue and Tissue Regeneration Applications

Industrial Applications

Biofuel and Renewable Energy

Biomaterials and Green Chemicals

Industrial Enzymes, by Application

Textile Industry

Paper Industry

Consumer Care Industry

Skin Care & Cosmetics

Other Consumer Care Products

Other Industries

Food & Agriculture

Environmental Applications

Bioremediation

Biosensing

On the basis of Region

Asia Pacific

North America

Europe

South America

Middle East & Africa

Browse For More Trending Reports:

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[marketresearch-articles]

Agricultural Biotechnology Market Status and Outlook 2022-2029, Emerging Technologies, Industry Size and Share, Analysis of Covid-19 Impact, Competitive Strategies

Agricultural Biotechnology Market is grow at a CAGR 10.44% in the forecast 2022 to 2029.

Agricultural Biotechnology Market Scope and Size

·        On the basis of type, the agricultural biotechnology market is segmented into molecular diagnostics, molecular markers, tissue culture, vaccines, genetic engineering, and others.

·        On the basis of application, the agricultural biotechnology market is bifurcated into transgenic crops, flower culturing, nutritional supplements, biofuels, antibiotic development, vaccine development and others.

·        On the basis of organism type, the agricultural biotechnology market is divided into plants, animals, microbes, and others.

·        On the basis of technology, the agricultural biotechnology market is fragmented into genome editing tools, ribonucleic acid interference [RNAi], biochips, deoxy ribonucleic acid [DNA] sequencing, and synthetic biology.

·        Based on the product, the agricultural biotechnology market is segregated into crop protection products, transgenic seeds, and synthetic biology-enables products. Crop protection products are further sub-categorized into biostimulants, and biopesticides. Transgenic seeds are further sub-segmented into soybean, fruits and vegetables, maize, cotton, and others.

.

Get the sample copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-agricultural-biotechnology-market

Agricultural Biotechnology Market Country Level Analysis

The global agricultural biotechnology market is segmented on the product type, livestock, source and form.

 The countries covered in the agricultural biotechnology market report are U.S., Canada, Mexico in North America, Germany, Poland, Ireland, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Chile, Rest of South America as a part of South America, UAE, Saudi Arabia, Egypt, Kuwait, South Africa, Rest of Middle East and Africa(MEA) as a part of Middle East and Africa(MEA).

MAJOR TOC OF THE REPORT

Chapter One: Agricultural Biotechnology Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Agricultural Biotechnology Market Competition, by Players

Chapter Four: Global Agricultural Biotechnology Market Size by Regions

Chapter Five: North Agricultural Biotechnology Market by Countries

Chapter Six: Europe Agricultural Biotechnology Market Revenue by Countries

Chapter Seven: Asia-Pacific Agricultural Biotechnology Market Revenue by Countries

Chapter Eight: South Agricultural Biotechnology Market Revenue by Countries

Chapter Nine: Middle East and Agricultural Biotechnology Market Revenue Equipment by Countries

Chapter Ten: Global Agricultural Biotechnology Market Segment by Type

Chapter Eleven: Global Agricultural Biotechnology Market by Application

Get TOC Details:   https://www.databridgemarketresearch.com/toc/?dbmr=global-agricultural-biotechnology-market

major players operating in the agricultural biotechnology market are KWS SAAT SE & Co. KGaA, ChemChina, Corteva., Limagrain, MITSUI & CO., LTD., AgPlenus ltd., Biomica, Evogene Ltd., Canonic ltd., Bayer AG, Valent BioSciences LLC, Nufarm Limited, Marrone Bio Innovations., Performance Plants Inc., ADAMA Ltd.. Cargill, Incorporated., DuPont., Kemin Industries, Inc., Novozymes and DSM among others.

Access Full Report   https://www.databridgemarketresearch.com/reports/global-agricultural-biotechnology-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Browse Related Reports@

Global Agricultural  fogging machines market

Global agriculture  grade zinc chemicals market

Global Agriculture  Seeder Market

Global Aluminium Nickel  Catalyst Market

[healthcare-domain]

Trends | Future and Growth for Preparative and Process Chromatography Market

The growth of this market is driven by the increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, increasing awareness about the advancements in preparative and process chromatography, increasing food safety concerns, and growing government investments for synthetic biology and genome projects

"Process Chromatography are expected to hold the largest share of the preparative and process chromatography market, by type in 2021."

Based on type, the market has been segmented into process chromatography and preparative chromatography. In 2020, the process chromatography segment accounted for the largest share of the market. This is mainly due to the increasing production of pharmaceutical products and rising investments in the pharma biotech industry. Moreover, with the outbreak of COVID-19, there has been a rise in demand for vaccines and drugs for treatment, hence driving the demand for process chromatography products.

"Biotechnology & pharmaceutical Industries are expected to hold the largest share of the preparative and process chromatography market, by end user in 2021."

Based on end user, the preparative chromatography market has been segmented into biotechnology & pharmaceutical industries; food and nutraceutical industries; and research laboratories. The biotechnology & pharmaceutical industries segment accounted for the largest market share in 2020. This can primarily be attributed to the increasing research activities by pharmaceutical & biotechnological companies and the rising demand for monoclonal antibodies and insulin by these industries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=151748164

"North America commanded the largest share of the preparative and process chromatography market in 2021."

Based on region, the preparative chromatography market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2020, North America commanded the largest share of the market.  

[330 Pages Report] The preparative and process chromatography market is projected to reach USD 12.8 billion by 2026 from USD 9.3 billion in 2021, at a CAGR of 6.7% from 2021 to 2026. Factors such as, increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, increasing awareness about the advancements in preparative and process chromatography, increasing food safety concerns, and growing government investments for synthetic biology and genome projects to drive the growth of the market during the forecast period.

The battle against the deadly SARS-CoV-2 virus continues, researchers rely on analytical laboratory techniques like chromatography to provide effective and efficient methods for characterizing the virus and analyzing potential vaccines and anti-COVID-19 compounds.

The large share of North America can be attributed to the rising demand of monoclonal antibodies primarily drives the market growth in this region, high adoption of technologically advanced solutions, growing investments in life sciences & biotechnology (along with advances in the pharmaceutical and biotechnology industries), a large number of ongoing clinical research studies, rising R&D expenditure by pharmaceutical & biotechnology companies, and the presence of major players in the region.

The major players operating in this Preparative and Process Chromatography Market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Waters Corporation (France), Novasep Holding S.A.S. (France), Daicel Corporation (Japan), PerkinElmer, Inc. (US), Hitachi High-Tech Corporation (Japan), GL Sciences, Inc. (Japan), Sartorius AG (Germany), Repligen Corporation (US), and Trajan Scientific and Medical (Australia).

For More Info, Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151748164

[researchinhealthcare]

Genetic Testing Market 2020 Growth Drivers, Regional Outlook, Competitive Strategies and Forecast up to 2027

Genetic Testing Market Overview :

As per the assessment conducted by Market Research Future (MRFR), the global market for the genetic testing market is estimated to garner a market value of USD 30.10 Billion while thriving at a CAGR of 10.30% by 2027. Genetic testing is used in prenatal screening, diagnostics, and as a predictive tool.

The on-going technical development in genetic testing is anticipated to play a significant role in developing the global genetic testing market during the forecast period. The rising demand for genetic testing in oncology and the increasing adoption of genetic tests into clinical care is another salient factor that can drive the regional market. Furthermore, the growing demand for personalized medicine can be recognized a crucial factor that can augment the market size in the assessment timeframe. On the contrary, lack of expertise in developing and underdeveloped countries is expected to hamper the market growth. In addition, the high expenses associated with genetic testing is likely to affect the adoption rate and inhibit the market rise.

The outbreak of COVID-19 is likely to bring a negative impact on the market growth due to the temporary shutdown of testing labs and clinics, which brought a negative impact on the market.

Genetic Testing Market Segmentation :

The global market for the genetic testing market can be segmented into method, type, and application.

The method-based segments of the global genetic testing market are molecular genetic tests/ DNA tests, chromosomal genetic tests, and biochemical, genetic tests. Among all, the molecular genetic test/DNA tests is anticipated to procure a market share of 11.78% during the review time.

The type-based segments of the global genetic testing market are prescribed genetic testing and direct to consumer genetic testing. Among all, the prescribed genetic testing is anticipated to procure a major market share while expanding at the highest CAGR by 2024.

The application-based segments of the global genetic testing market are reproductive health, cancer screening, ancestry, predictive and pre-symptomatic testing, and others. Among all, the reproductive health segment is anticipated to lead the segment in the assessment tenure.

Get Sample Copy on :- https://www.marketresearchfuture.com/sample_request/2009

Genetic Testing Market Regional Analysis :

As per the assessment conducted by MRFR, the Americas is anticipated to lead the global market during the forecast period. The region is expected to thrive at the maximum CAGR in the coming time. The increasing demand for personalized genetic testing and the favorable initiatives taken by the government are other salient causes that can grow the market in the coming time. APAC is anticipated to be the fastest-growing region during the review time. The increasing adoption of a sedentary lifestyle and the growing consumption of junk food is likely to play a salient role in driving the regional market in the assessment tenure. Developing countries such as; India and China are anticipated to make a notable contribution in developing the industry in the coming time. On the other hand, MEA is likely to witness the growing adoption of technology and increased government initiatives that can improve the healthcare infrastructure. In addition, the increasing prevalence of metabolic diseases in the region is likely to increase the demand for genetic testing and augment the market share of the region.

Competitive Landscape :

Genetic testing has seen increased demand over the years, due to the rapid expansion of the biotechnology and integration of AI in testing procedures. Companies functioning in the global Global Market are also being challenged due to the lack of funded research in prognosis and shortage of skilled professionals. Mergers and acquisitions by Global Market companies are anticipated to help the market during the forecast period 2020 to 2027. the report highlights key areas companies need to focus on. The report suggests that the Global Market will see a healthy growth in the long run till 2027. Based on SWOT analysis and genetic testing market’s analysis based on Porters’ Five Force Model presented in the Global Market report. Mergers and acquisitions by Global Market companies are anticipated to help the market during the forecast period 2020 to 2027.

Genetic Testing Market Key Players :

Some of the renowned players of the global genetic testing market are Blueprint Genetics (Finland), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Myriad Genetics, Inc. (US), Illumina Inc. (US),  QIAGEN N. V.  (Germany), Eurofins Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (US), Quest Diagnostics Incorporated (US), BGI Genomics (China), and Thermo Fisher Scientific Inc. (US).

Genetic Testing Industry News :

February 2021- Seneca Therapeutics has expanded its R&D pipeline to include six new armed gene therapy/oncolytic constructs directed against important cancer targets and indications.

February 2021– Scientists in Beijing have developed a new gene therapy that can reverse some of the effects of aging in mice and increase their lifespans. The therapy can be fruitful for humans in the future.

February 2021- Taysha Gene Therapies, a patient-centric, clinical-stage gene therapy company, which is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS, announced their collaborations with Cleveland Clinic and UT Southwestern Gene Therapy Program (UTSW_ to advance next-generation mini-gene payloads for AAV gene therapies for the treatment of genetic epilepsies and additional CNS disorders.

February 2021– Paragon Biosciences, a life science innovator, and cell and gene therapy and synthetic biology utilizing AI, has launched CiRC Biosciences, a cell therapy company, developing a treatment for severe diseases with an initial focus on the eye.

Get Report information on :- https://www.marketresearchfuture.com/reports/genetic-testing-market-2009

[simranmakhija1]

Addressing Challenges in Oligonucleotide Synthesis: Quality, Scale, and Efficiency

The Oligonucleotide Synthesis Market is experiencing rapid growth driven by advancements in genomics, personalized medicine, and molecular diagnostics. Oligonucleotides, short sequences of nucleotides, are essential tools in various applications, including DNA sequencing, gene editing, PCR amplification, and RNA interference. The increasing demand for custom oligonucleotides for research, diagnostic, and therapeutic purposes is fueling the expansion of the oligonucleotide synthesis market.

Get a free Sample: https://www.marketdigits.com/request/sample/4550 

One of the key drivers of market growth is the rising adoption of oligonucleotide-based therapies, such as antisense oligonucleotides (ASOs), siRNAs, and aptamers, for the treatment of genetic disorders, cancer, and infectious diseases. Oligonucleotide therapeutics offer targeted and specific modes of action, allowing for precision medicine approaches and reduced off-target effects compared to traditional small molecule drugs. As a result, pharmaceutical companies and biotech firms are investing heavily in oligonucleotide drug discovery and development, driving the demand for high-quality oligonucleotide synthesis services.

The Oligonucleotide Synthesis Market is Valued USD 8.4 billion in 2024 and projected to reach USD 22.9 billion by 2030, growing at a CAGR of CAGR of 15.5% During the Forecast period of 2024-2032.

In addition to therapeutics, oligonucleotides are widely used in research and diagnostics for studying gene expression, identifying genetic mutations, and detecting infectious agents. The growing demand for personalized medicine and companion diagnostics is driving the need for custom oligonucleotide probes and primers tailored to individual patient profiles. Furthermore, advancements in next-generation sequencing (NGS) technologies and gene editing tools, such as CRISPR-Cas9, are driving the demand for high-throughput oligonucleotide synthesis platforms capable of producing large quantities of oligos with high purity and fidelity.

Major vendors in the global Oligonucleotide Synthesis market are Agilent Technologies, Inc., Biolegio, Biolytic Lab Performance Inc., Bio-Synthesis Inc., Cytiva, DH Life Sciences, LLC., GENERI BIOTECH, Horizon Discovery Ltd., Kaneka Eurogentec S.A, LGC Limited, Maravai LifeSciences, Thermo Fisher Scientific Inc., Twist Bioscience.,  and Others.

The oligonucleotide synthesis market is characterized by the presence of both established players and emerging startups offering a wide range of synthesis platforms and services. Major players in the market include Integrated DNA Technologies, Inc. (IDT), Merck KGaA, Thermo Fisher Scientific Inc., Eurofins Scientific SE, and Bio-Synthesis, Inc., among others. These companies provide custom oligonucleotide synthesis services, as well as a variety of oligo modifications, purification methods, and quality control assays to meet the diverse needs of researchers and clinicians.

Emerging trends in the oligonucleotide synthesis market include the development of novel synthesis chemistries, automation technologies, and digital solutions for designing and ordering custom oligos. Continuous innovation in oligonucleotide synthesis platforms, such as microarray-based synthesis, solid-phase synthesis, and enzymatic synthesis, is driving improvements in oligo yield, length, and quality, enabling new applications in synthetic biology, nanotechnology, and drug delivery.

Looking ahead, the oligonucleotide synthesis market is poised for further expansion driven by advancements in gene therapy, nucleic acid-based vaccines, and precision diagnostics. As the field of genomics continues to evolve, the demand for custom oligonucleotide synthesis services will continue to grow, offering new opportunities for market players to innovate and collaborate in addressing unmet needs in healthcare and life sciences research.

[hurtworld]

mesaj attım ama cevap vermedin dostum. PCR ve qPCR teknikleriyle alakalı kaynak olarak yardımcı olabilir misin?

mendeley kullanıyor musun bilmiyorum ama ben APA şeklinde buraya atayım kaynakları sen seç beğen al dostum.

Polymerase chain reaction - Wikipedia. (n.d.). Retrieved May 27, 2020, from https://en.wikipedia.org/wiki/Polymerase_chain_reaction

Citations for Chemical Breakthrough Awards 2017 Awardees. (n.d.). Division of the History of Chemistry. Retrieved May 27, 2020, from http://www.scs.illinois.edu/~mainzv/HIST/awards/CCB-2017_Awardees.php

Kary B. Mullis – Nobel Lecture: The Polymerase Chain Reaction. (n.d.). Retrieved May 27, 2020, from http://nobelprize.org/nobel_prizes/chemistry/laureates/1993/mullis-lecture.html

Advice on How to Survive the Taq Wars. (2006). GEN Genetic Engineering News – Biobusiness Channel, 26(9). https://www.genengnews.com/magazine/49/advice-on-how-to-survive-the-taq-wars/

Babineaux, M. J., & Alter, M. J. (2011). Viral Hepatitis. In Netter’s Infectious Disease (pp. 399–410). Elsevier Inc. https://doi.org/10.1016/B978-1-4377-0126-5.00067-7

Key ingredient in coronavirus tests comes from Yellowstone’s lakes. (2020). Science. https://www.nationalgeographic.com/science/2020/03/key-ingredient-in-coronavirus-tests-comes-from-yellowstone/

Bing, D., Boles, C., Rehman, F., Audeh, M., Belmarsh, M., Kelley, B., & Adams, C. (1996). Bridge amplification: a solid phase PCR system for the amplification and detection of allelic differences in single copy genes. Genetic Identity Conference Proceedings, Seventh International Symposium on Human Identification. http://www.promega.com/geneticidproc/ussymp7proc/0726.html

Tomar, R. S. (2010). Molecular markers & plant biotechnology. New India Pub. Agency.

Full Text – LaNe RAGE: a new tool for genomic DNA flanking sequence determination. (n.d.). Retrieved May 27, 2020, from http://www.ejbiotechnology.info/content/vol8/issue2/full/7/index.html

Kieleczawa, J. (2006). DNA sequencing II : optimizing preparation and cleanup. Jones and Bartlett Publishers.

David, F. (2002). Utiliser les propriétés topologiques de l’ADN: une nouvelle arme contre les agents pathogènes. Fusion. http://www.lab-rech-associatives.com/pdf/Utiliser la Topologie de l’ADN.pdf

Kellogg, D. E., Rybalkin, I., Chen, S., Mukhamedova, N., Vlasik, T., Siebert, P. D., & Chenchik, A. (1994). TaqStart antibody(TM): “Hot start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. BioTechniques, 16(6), 1134–1137.

Ochman, H., Gerber, A. S., & Hartl, D. L. (1988). Genetic applications of an inverse polymerase chain reaction. Genetics, 120(3), 621–623.

Ninfa, A. B. et all. (2010). Fundamental laboratory Approaches for Biochemistry and Biotechnology about PAGE. In Fundamental laboratory Approaches for Biochemistry and Biotechnology. John Wiley & Sons. inc.

Boehnke, M., Arnheim, N., Li, H., & Collins, F. S. (1989). Fine-structure genetic mapping of human chromosomes using the polymerase chain reaction on single sperm: Experimental design considerations. American Journal of Human Genetics, 45(1), 21–32.

Coronavirus: il viaggio dei test. (n.d.). Istituto Superiore Di Sanità. Retrieved May 27, 2020, from https://www.iss.it/web/guest/primo-piano/-/asset_publisher/o4oGR9qmvUz9/content/id/5269706

Patidar, M., Agrawal, S., Parveen, F., & Khare, P. (2015). Molecular insights of saliva in solving paternity dispute. Journal of Forensic Dental Sciences, 7(1), 76. https://doi.org/10.4103/0975-1475.150325

Chemical Synthesis, Sequencing, and Amplification of DNA (class notes on MBB/BIO 343). (n.d.). Arizona State University. Retrieved May 27, 2020, from http://photoscience.la.asu.edu/photosyn/courses/BIO_343/lecture/DNAtech.html

Electronic PCR. (n.d.). NCBI – National Center for Biotechnology Information. Retrieved May 27, 2020, from https://www.ncbi.nlm.nih.gov/sutils/e-pcr/

Bogetto, P. and W. L. (2000). Helpful tips for PCR. Focus, 22(1), 12. http://tools.thermofisher.com/Content/Focus/Focus Volume 22 Issue 1.pdf

Mullis, K. B. (1990). The unusual origin of the polymerase chain reaction. Scientific American, 262(4), 56–65. https://doi.org/10.1038/scientificamerican0490-56

Borman, J., Schuster, D., Li, W., Jessee, J., & Rashtchian, A. (2000). PCR from problematic templates. Focus, 22(1), 10. http://tools.thermofisher.com/Content/Focus/Focus Volume 22 Issue 1.pdf

Mullis, K. B. (1998). Dancing naked in the mind field. Pantheon Books. https://archive.org/details/dancingnakedinmi00mull

PCR. (n.d.). Genetic Science Learning Center, University of Utah. Retrieved May 27, 2020, from http://learn.genetics.utah.edu/content/labs/pcr/

Polymerase Chain Reaction (PCR). (n.d.). National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved May 27, 2020, from https://www.ncbi.nlm.nih.gov/probe/docs/techpcr/

Rabinow, P. (1996). Making PCR : a story of biotechnology. University of Chicago Press. https://archive.org/details/makingpcrstoryof00rabi

Park, D. J. (2005). A new 5′ terminal murine GAPDH exon identified using 5′RACE LaNe. Molecular Biotechnology, 29(1), 39–46. https://doi.org/10.1385/MB:29:1:39

White, B. A. (1993). PCR protocols : current methods and applications. Humana Press.

Myrick, K. V., & Gelbart, W. M. (2002). Universal Fast Walking for direct and versatile determination of flanking sequence. Gene, 284(1–2), 125–131. https://doi.org/10.1016/S0378-1119(02)00384-0

McPherson, M. J., & Møller, S. G. (2006). PCR. Taylor & Francis.

Bagchi, D. (2013). Bio-nanotechnology : a revolution in food, biomedical, and health sciences. Wiley-Blackwell.

Liu, Y. G., & Whittier, R. F. (1995). Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking. Genomics, 25(3), 674–681. https://doi.org/10.1016/0888-7543(95)80010-J

Thornhill, A. (2007). Single Cell Diagnostics. Cell, 132. https://doi.org/10.1007/978-1-59745-298-4

Khan, Z., Poetter, K., & Park, D. J. (2008). Enhanced solid phase PCR: mechanisms to increase priming by solid support primers. Analytical Biochemistry, 375(2), 391–393. https://doi.org/10.1016/j.ab.2008.01.021

Baron, S. (1996). Medical microbiology (4th ed.). University of Texas Medical Branch at Galveston. https://www.ncbi.nlm.nih.gov/books/NBK7813/

Bustin, S. A., & Nolan, T. (2009). Analysis of mRNA Expression by Real-time. In Real-Time PCR: Current Technology and Applications. Caister Academic Press. http://www.caister.com/realtimepcr

White, B. A., Shyamala, V., & Ames, G. F.-L. (2003). Single Specific Primer-Polymerase Chain Reaction (SSP-PCR) and Genome Walking. In PCR Protocols (pp. 339–348). Humana Press. https://doi.org/10.1385/0-89603-244-2:339

Dobosy, J. R., Rose, S. D., Beltz, K. R., Rupp, S. M., Powers, K. M., Behlke, M. A., & Walder, J. A. (2011). RNase H-dependent PCR (rhPCR): Improved specificity and single nucleotide polymorphism detection using blocked cleavable primers. BMC Biotechnology, 11, 80. https://doi.org/10.1186/1472-6750-11-80

Sambrook, J., & Russell, D. W. (David W. (2001). Molecular cloning : a laboratory manual (3rd ed.). Cold Spring Harbor Laboratory Press. https://archive.org/details/molecularcloning0000samb_p7p5

David, F., & Turlotte, É. (1998). Une methode d’amplification genique isotherme. Comptes Rendus de l’Academie Des Sciences - Serie III, 321(11), 909–914. https://doi.org/10.1016/S0764-4469(99)80005-5

Shen, C., & Zhang, Z. (2013). An Overview of Nanoparticle-Assisted Polymerase Chain Reaction Technology. In Bio-Nanotechnology: A Revolution in Food, Biomedical and Health Sciences (pp. 97–106). Blackwell Publishing Ltd. https://doi.org/10.1002/9781118451915.ch5

Kleppe, K., Ohtsuka, E., Kleppe, R., Molineux, I., & Khorana, H. G. (1971). Studies on polynucleotides. XCVI. Repair replication of short synthetic DNA’s as catalyzed by DNA polymerases. Journal of Molecular Biology, 56(2), 341–361. https://doi.org/10.1016/0022-2836(71)90469-4

Park, D. J. (2004). 3′ RACE LaNe: A simple and rapid fully nested PCR method to determine 3′-terminal cDNA sequence. BioTechniques, 36(4), 586–590. https://doi.org/10.2144/04364bm04

Kim, B., Kim, J., Kim, M., Kim, B.-D., Jo, S., Park, S., Son, J., Hwang, S., Dugasani, S., Chang, I., Kim, M., & Liu, W. (2016). Ternary and senary representations using DNA double-crossover tiles. Nanotechnology, 10(45), 105601. https://doi.org/10.1088/0957-4484

Isenbarger, T. A., Finney, M., Ríos-Velázquez, C., Handelsman, J., & Ruvkun, G. (2008). Miniprimer PCR, a new lens for viewing the microbial world. Applied and Environmental Microbiology, 74(3), 840–849. https://doi.org/10.1128/AEM.01933-07

Raoult, D., Aboudharam, G., Crubézy, E., Larrouy, G., Ludes, B., & Drancourt, M. (2000). Molecular identification by “suicide PCR” of Yersinia pestis as the agent of Medieval Black Death. Proceedings of the National Academy of Sciences of the United States of America, 97(23), 12800–12803. https://doi.org/10.1073/pnas.220225197

Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996). Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America, 93(18), 9821–9826. https://doi.org/10.1073/pnas.93.18.9821

Zietkiewicz, E., Rafalski, A., & Labuda, D. (1994). Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification. Genomics, 20(2), 176–183. https://doi.org/10.1006/geno.1994.1151

San Millán, R. M., Martínez-Ballesteros, I., Rementeria, A., Garaizar, J., & Bikandi, J. (2013). Online exercise for the design and simulation of PCR and PCR-RFLP experiments. BMC Research Notes, 6(1), 513. https://doi.org/10.1186/1756-0500-6-513

Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., & Pease, L. R. (1989). Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene, 77(1), 61–68. https://doi.org/10.1016/0378-1119(89)90359-4

Schwartz, J. J., Lee, C., & Shendure, J. (2012). Accurate gene synthesis with tag-directed retrieval of sequence-verified DNA molecules. Nature Methods, 9(9), 913–915. https://doi.org/10.1038/nmeth.2137

Mueller, P. R., & Wold, B. (1989). In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science, 246(4931), 780–786. https://doi.org/10.1126/science.2814500

Priye, A., Hassan, Y. A., & Ugaz, V. M. (2013). Microscale chaotic advection enables robust convective DNA replication. Analytical Chemistry, 85(21), 10536–10541. https://doi.org/10.1021/ac402611s

Vincent, M., Xu, Y., & Kong, H. (2004). Helicase-dependent isothermal DNA amplification. EMBO Reports, 5(8), 795–800. https://doi.org/10.1038/sj.embor.7400200

Pierce, K. E., & Wangh, L. J. (2007). Linear-After-The-Exponential Polymerase Chain Reaction and Allied Technologies (pp. 65–85). https://doi.org/10.1007/978-1-59745-298-4_7

Krishnan, M., Ugaz, V. M., & Burns, M. A. (2002). PCR in a Rayleigh-Bénard convection cell. Science, 298(5594), 793. https://doi.org/10.1126/science.298.5594.793

Innis, M. A., Myambo, K. B., Gelfand, D. H., & Brow, M. A. D. (1988). DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proceedings of the National Academy of Sciences of the United States of America, 85(24), 9436–9440. https://doi.org/10.1073/pnas.85.24.9436

Stemmer, W. P. C., Crameri, A., Ha, K. D., Brennan, T. M., & Heyneker, H. L. (1995). Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene, 164(1), 49–53. https://doi.org/10.1016/0378-1119(95)00511-4

Alonso, A., Martín, P., Albarrán, C., García, P., García, O., Fernández De Simón, L., García-Hirschfeld, J., Sancho, M., De La Rúa, C., & Fernández-Piqueras, J. (2004). Real-time PCR designs to estimate nuclear and mitochondrial DNA copy number in forensic and ancient DNA studies. Forensic Science International, 139(2–3), 141–149. https://doi.org/10.1016/j.forsciint.2003.10.008

Yeh, S. H., & Mink, C. A. M. (2012). Bordetella pertussis and Pertussis (Whooping Cough). In Netter’s Infectious Disease (pp. 11–14). Elsevier Inc. https://doi.org/10.1016/B978-1-4377-0126-5.00003-3

Kwok, S., Mack, D. H., Mullis, K. B., Poiesz, B., Ehrlich, G., Blair, D., Friedman-Kien, A., & Sninsky, J. J. (1987). Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. Journal of Virology, 61(5), 1690–1694. https://doi.org/10.1128/jvi.61.5.1690-1694.1987

Cai, H. Y., Caswell, J. L., & Prescott, J. F. (2014). Nonculture Molecular Techniques for Diagnosis of Bacterial Disease in Animals: A Diagnostic Laboratory Perspective. In Veterinary Pathology (Vol. 51, Issue 2, pp. 341–350). https://doi.org/10.1177/0300985813511132

Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., Vandesompele, J., & Wittwer, C. T. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry, 55(4), 611–622. https://doi.org/10.1373/clinchem.2008.112797

Quill, E. (2008). Medicine: Bood-matching goes genetic. In Science (Vol. 319, Issue 5869, pp. 1478–1479). https://doi.org/10.1126/science.319.5869.1478

Garibyan, L., & Avashia, N. (2013). Polymerase chain reaction. Journal of Investigative Dermatology, 133(3), 1–4. https://doi.org/10.1038/jid.2013.1

Movert, E., Wu, Y., Lambeau, G., Kahn, F., Touqui, L., & Areschoug, T. (2013). Using Patient Pathways to Accelerate the Drive to Ending Tuberculosis. Journal of Infectious Diseases, 208(12), 2025–2035. https://doi.org/10.1093/INFDIS

Lawyer, F. C., Stoffel, S., Saiki, R. K., Chang, S. Y., Landre, P. A., Abramson, R. D., & Gelfand, D. H. (1993). High-level expression, purification, and enzymatic characterization of full-length Thermus aquaticus DNA polymerase and a truncated form deficient in 5′ to 3′ exonuclease activity. Genome Research, 2(4), 275–287. https://doi.org/10.1101/gr.2.4.275

Pombert, J. F., Sistek, V., Boissinot, M., & Frenette, M. (2009). Evolutionary relationships among salivarius streptococci as inferred from multilocus phylogenies based on 16S rRNA-encoding, recA, secA, and secY gene sequences. BMC Microbiology, 9, 232. https://doi.org/10.1186/1471-2180-9-232

Chien, A., Edgar, D. B., & Trela, J. M. (1976). Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus. Journal of Bacteriology, 127(3), 1550–1557. https://doi.org/10.1128/jb.127.3.1550-1557.1976

Sharkey, D. J., Scalice, E. R., Christy, K. G., Atwood, S. M., & Daiss, J. L. (1994). Antibodies as thermolabile switches: High temperature triggering for the polymerase chain reaction. Bio/Technology, 12(5), 506–509. https://doi.org/10.1038/nbt0594-506

Carr, A. C., & Moore, S. D. (2012). Robust quantification of polymerase chain reactions using global fitting. PLoS ONE, 7(5), e37640. https://doi.org/10.1371/journal.pone.0037640

Rhizobium, G. E. (2013). Complete Genome Sequence of the Sesbania Symbiont and Rice. Nucleic Acids Research, 1(1256879), 13–14. https://doi.org/10.1093/nar

Pavlov, A. R., Pavlova, N. V., Kozyavkin, S. A., & Slesarev, A. I. (2004). Recent developments in the optimization of thermostable DNA polymerases for efficient applications. In Trends in Biotechnology (Vol. 22, Issue 5, pp. 253–260). https://doi.org/10.1016/j.tibtech.2004.02.011

Determining Annealing Temperatures for Polymerase Chain Reaction. (2012). The American Biology Teacher, 74(4), 256–260. https://doi.org/10.1525/abt.2012.74.4.9

Cheng, S., Fockler, C., Barnes, W. M., & Higuchi, R. (1994). Effective amplification of long targets from cloned inserts and human genomic DNA. Proceedings of the National Academy of Sciences of the United States of America, 91(12), 5695–5699. https://doi.org/10.1073/pnas.91.12.5695

Saiki, R., Gelfand, D., Stoffel, S., Scharf, S., Higuchi, R., Horn, G., Mullis, K., & Erlich, H. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239(4839), 487–491. https://doi.org/10.1126/science.239.4839.487

Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985). Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230(4732), 1350–1354. https://doi.org/10.1126/science.2999980